Stony Brook, NY, United States of America

Xun Jiang

This inventor holds 7 USPTO granted patents and 12 published patent applications and 3 EPO patents. Top assignee: Icell Gene Therapeutics LLC. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xun Jiang. Retrieved from https://idiyas.com/inventor/xun-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 12)

% Patents Active = 85.7

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

7 out of 7

Icell Gene Therapeutics LLC

patents

Years Active: 2019-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735471 - CHIMERIC ANTIGEN RECEPTORS (CARs) TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOF (2026-09-15),

2. 12275787 - Chimeric antigen receptors (CARs), compositions and methods thereof (2025-04-14),

3. 11905528 - Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof (2024-02-20),

4. 11820819 - Chimeric antigen receptors (CARs), compositions and methods thereof (2023-11-21),

5. 11655452 - Chimeric antigen receptors (CARs), compositions and methods of use thereof (2023-05-23),

6. 11173179 - Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof (2021-11-16),

7. 10273280 - Chimeric antigen receptors (CARs), targeting hematologic malignancies, compositions and methods of use thereof (2019-04-30),

Title: The Innovative Contributions of Xun Jiang

Introduction

Xun Jiang is a prominent inventor based in Stony Brook, NY, known for his significant contributions to the field of gene therapy. With a total of six patents to his name, Jiang has made remarkable strides in developing innovative solutions for various medical challenges.

Latest Patents

Among his latest patents is a groundbreaking invention related to chimeric antigen receptors (CARs), which includes compositions and methods for treating autoimmune diseases, asthma, and preventing or mediating organ rejection in subjects. This patent outlines a method that leverages engineered cells to enhance therapeutic outcomes. Another notable patent focuses on a compound chimeric antigen receptor (cCAR) that targets multiple antigens. This invention details an engineered cell that incorporates two distinct chimeric antigen receptor polypeptides, each with unique antigen recognition domains, thereby expanding the potential for targeted therapies.

Career Highlights

Xun Jiang is currently affiliated with Icell Gene Therapeutics LLC, where he continues to push the boundaries of gene therapy research. His work has been instrumental in advancing the understanding and application of CAR technology in clinical settings.

Collaborations

Jiang collaborates with esteemed colleagues, including Yupo Ma and Kevin Pinz, who contribute to the innovative research environment at Icell Gene Therapeutics LLC.

Conclusion

Xun Jiang's contributions to the field of gene therapy, particularly through his patents on chimeric antigen receptors, highlight his role as a leading inventor in medical innovation. His ongoing work promises to impact the treatment of various diseases significantly.

Profile summary based on public USPTO records.